Choose the brand aligned with your industry so we can best serve your needs.
For researchers, scientists, and technical professionals: Your one-stop shop for the complete range of laboratory, production, and safety products and services.
Organic compounds that consist of a phenol ring with a ciclohexane substitution; includes compounds in which the ciclohexane group has additional substitutions.
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
Imifoplatin (PT-112) is a platinum-based active molecule, categorized within the phosphaplatins family. It is known for its ability to induce apoptosis and demonstrates significant antitumor activity. This compound has been investigated for its potential in treating various cancers, showing promising results in both *in vitro* and *in vivo* studies, particularly in inhibiting proliferation and inducing apoptosis in cancer cell lines.
Induces apoptosis.
Exhibits antitumor activity.
Shows dose-dependent proliferation inhibition in cancer cells.
Significantly increases mitochondrial reactive oxygen species (mtROS).
Demonstrates potent antitumor immune effects in xenograft models.
Shows synergistic antitumor effects when combined with immune checkpoint blockers.
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
Imifoplatin (PT-112) is a platinum-based active molecule and a member of the phosphaplatins family. Imifoplatin can induce Apoptosis and exhibits antitumor activity.
Inhibits proliferation in HCT116 cells.
Induces apoptosis in HCT116 cells.
Inhibits proliferation in CT26 cells.
Shows selectivity, strongly inhibiting glycolytic tumor cells with mtDNA mutations.
Increases mtROS, especially in glycolytic L929dt and Cybrid cells.
Demonstrates potent antitumor immune effects in the CT26 xenograft model.
Shows synergistic antitumor effects in the MC38 xenograft model, especially with PD-1 blockade.
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More